Lv11
60 积分 2024-02-20 加入
Index Medicus Update
27天前
已关闭
AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification
1个月前
已完结
AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification
1个月前
已关闭
AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification
1个月前
已关闭
Hydroxyurea achieved a hematologic response in a patient with β‐thalassemia and secondary severe thrombocytosis post splenectomy
3个月前
已完结
Hydroxyurea therapy
3个月前
已关闭
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
4个月前
已完结
Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience
4个月前
已完结
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
5个月前
已完结
Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment
5个月前
已完结
皖公网安备34019202002308
